SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-18-008349
Filing Date
2018-03-22
Accepted
2018-03-22 17:33:28
Documents
1
Period of Report
2018-03-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 9702
  Complete submission text file 0000899243-18-008349.txt   11952
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Issuer) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 285 RIVERSIDE AVE. SUITE 250 WESTPORT CT 06880
Business Address 285 RIVERSIDE AVE. SUITE 250 WESTPORT CT 06880 203-855-0400
CANAAN X L.P. (Reporting) CIK: 0001619859 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37852 | Film No.: 18707787

Mailing Address 2765 SAND HILL ROAD MENLO PARK CA 94025
Business Address 2765 SAND HILL ROAD MENLO PARK CA 94025 6508548092
Canaan Partners X LLC (Reporting) CIK: 0001673228 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37852 | Film No.: 18707786